NCT00538031View on ClinicalTrials.gov

Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 22, 2003

Primary Completion Date

April 21, 2011

Study Completion Date

September 13, 2019

Conditions
Fallopian Tube CancerPeritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Interventions
DRUG

cyclophosphamide

Given orally

DRUG

celecoxib

Given orally

Trial Locations (2)

91010

City of Hope, Duarte

91105

City of Hope Medical Group Inc, Pasadena

All Listed Sponsors
lead

City of Hope Medical Center

OTHER

NCT00538031 - Cyclophosphamide With or Without Celecoxib in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter